November 20, 2014 : Episode 4

Video

Pre-Chemo Abiraterone Extends Survival in CRPC

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
Ami Umesh Badami, MD, medical oncologist, Endeavor Health Medical Group
2 experts are featured in this series.
2 experts are featured in this series.
Katherine L. Nathanson, MD
Thomas Westbrook, MD, assistant professor, Department of Internal Medicine, Rush University
Stephanie L. Graff, MD
Stephanie L. Graff, MD
5 experts are featured in this series
Related Content
FDA
January 20th 2025

FDA Grants Breakthrough Device Designation to DCISionRT for Breast Cancer With DCIS

MedNews Week
January 1st 2025

DESTINY-Breast06 Data Demonstrate the Role of T-DXd in HER2-Low and -Ultralow Breast Cancer: With Chandler Park, MD; and Guiseppe Curigliano, MD, PhD

Sotorasib doublet gets approved for KRAS G12C–mutated CRC, acalabrutinib triplet is cleared for previously untreated MCL, and more from OncLive.
January 18th 2025

The OncFive: Top Oncology Articles for the Week of 1/12

Oncology Unplugged
November 6th 2024

Review Key Genitourinary Cancer Data From the 2024 ESMO Congress With Chandler Park, MD

Ovarian Cancer | © Sebastian Kaulitzki - stock.adobe.com
January 17th 2025

Senaparib Receives NMPA Approval As First-Line Maintenance in Ovarian Cancer

FDA
January 17th 2025

FDA Approves Companion Diagnostic for Tovorafenib in BRAF-Altered Pediatric Low-Grade Glioma